CloudMD Software & Services (CVE:DOC) Price Target Lowered to C$0.33 at Echelon Wealth Partners

CloudMD Software & Services (CVE:DOCFree Report) had its target price decreased by Echelon Wealth Partners from C$0.40 to C$0.33 in a report issued on Tuesday morning, BayStreet.CA reports. Echelon Wealth Partners currently has a speculative buy rating on the stock.

CloudMD Software & Services Price Performance

CloudMD Software & Services stock opened at C$0.17 on Tuesday. CloudMD Software & Services has a one year low of C$0.12 and a one year high of C$0.38. The business has a fifty day moving average price of C$0.14 and a 200-day moving average price of C$0.17. The company has a debt-to-equity ratio of 23.37, a current ratio of 1.29 and a quick ratio of 1.14. The firm has a market capitalization of C$49.78 million, a P/E ratio of -0.32 and a beta of 0.84.

CloudMD Software & Services (CVE:DOCGet Free Report) last posted its quarterly earnings data on Monday, May 29th. The company reported C($0.02) earnings per share (EPS) for the quarter, meeting the consensus estimate of C($0.02). The company had revenue of C$26.14 million during the quarter, compared to analyst estimates of C$26.82 million. CloudMD Software & Services had a negative return on equity of 79.53% and a negative net margin of 145.52%. As a group, equities research analysts forecast that CloudMD Software & Services will post 0.01 EPS for the current year.

About CloudMD Software & Services

(Get Free Report)

CloudMD Software & Services Inc offers healthcare services in Canada and the United States. The company operates in two segments: Digital Health Solutions and Enterprise Health Solutions. It offers enterprise health solutions, including mental health, virtual medical care, healthcare navigation, rehabilitation and assessments, education, employee and family assistance program, and absence management and occupational health.

See Also

Receive News & Ratings for CloudMD Software & Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CloudMD Software & Services and related companies with's FREE daily email newsletter.